2021
DOI: 10.1016/j.csbj.2021.08.046
|View full text |Cite
|
Sign up to set email alerts
|

MicroRNA-regulated transcriptome analysis identifies four major subtypes with prognostic and therapeutic implications in prostate cancer

Abstract: Graphical abstract

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 53 publications
0
4
0
Order By: Relevance
“…miRNAs are mentioned in literature as a potential application of biomarkers for numerous diseases, 7 , 9 , 18 including prostate adenocarcinoma (PRAD). 19 Despite this, there is a current lack of validated studies that evaluated the miRNA expression level and direct connection with clinical variables, particularly from the liquid biopsy. 20 , 21 Recent literature data emphasizes the important role of liquid biopsy in patient stratification.…”
Section: Introductionmentioning
confidence: 99%
“…miRNAs are mentioned in literature as a potential application of biomarkers for numerous diseases, 7 , 9 , 18 including prostate adenocarcinoma (PRAD). 19 Despite this, there is a current lack of validated studies that evaluated the miRNA expression level and direct connection with clinical variables, particularly from the liquid biopsy. 20 , 21 Recent literature data emphasizes the important role of liquid biopsy in patient stratification.…”
Section: Introductionmentioning
confidence: 99%
“…Given the tissue specificity of microRNA expression, we performed this study within a single tissue type. We chose the PRAD cohort because it is large and extensively studied for microRNAs [ 20 , 21 , 22 , 23 ]; in addition, PRAD is a very heterogeneous cancer, thus biases due to major cancer subtypes are unlikely [ 24 ]. We investigated the expression of the conserved human microRNAs (221 out of the 2606 microRNA entries available in Targetscan 7.2) and all the human protein-coding transcripts annotated in Ensembl (20,440) in the 546 samples of the PRAD-TCGA cohort (20,531 genes and 2588 microRNAs expressed) (see pipeline analysis in Figure 1 ).…”
Section: Resultsmentioning
confidence: 99%
“…Given the tissue specificity of microRNA expression, we performed this study within a single tissue type. We chose the PRAD cohort because it is large and extensively studied for microRNAs (Lin et al, 2021; Wei et al, 2020; Yang et al, 2019; Ye et al, 2018); in addition, PRAD is a very heterogeneous cancer thus biases result in of cancer subtypes are unlikely (Abeshouse et al, 2015). We investigated the expression of the conserved human microRNAs (221) and all the human protein-coding transcripts annotated in Ensembl (20,440) in the 546 samples of the PRAD-TCGA cohort (20,531) (see pipeline analysis in Figure 1).…”
Section: Resultsmentioning
confidence: 99%